Catheter Precision, Inc. (VTAK)
| Market Cap | 2.11M -16.8% |
| Revenue (ttm) | 1.11M +130.4% |
| Net Income | -16.18M |
| EPS | -10.94 |
| Shares Out | 2.69M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 97,913 |
| Open | 0.8100 |
| Previous Close | 0.8230 |
| Day's Range | 0.7501 - 0.8230 |
| 52-Week Range | 0.7501 - 15.6810 |
| Beta | 0.32 |
| Analysts | Strong Buy |
| Price Target | 38.00 (+4,753.13%) |
| Earnings Date | May 18, 2026 |
About VTAK
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing... [Read more]
Financial Performance
In 2025, Catheter Precision's revenue was $819,000, an increase of 95.00% compared to the previous year's $420,000. Losses were -$17.18 million, -21.18% less than in 2024.
Financial StatementsAnalyst Summary
According to one analyst, the rating for VTAK stock is "Strong Buy" and the 12-month stock price target is $38.0.
News
Catheter Precision Quarterly report: Q1 2026
Catheter Precision has published its Q1 2026 quarterly earnings report on May 18, 2026.
Catheter Precision Earnings release: Q1 2026
Catheter Precision released its Q1 2026 earnings on May 18, 2026, summarizing the period's financial results.
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND
Company Deploys Scalable Short-Haul Model Following Kentucky Derby to Monetize Peak Travel Window Flagship Routes from NYC, Boston, DC, and Philadelphia Positioned to Drive Immediate Revenue, High Uti...
Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel
Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals Premium Short-Haul Operator Continues Planned Vision J...
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand
Positioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha's Vineyard Scalable Short-Haul Luxury Aviation Platform Targeting Key Regional Travel Markets F...
Catheter Precision secures U.S. patent allowance on surgical vessel device
Catheter Precision (VTAK) announced that the United States Patent and Trademark Office, USPTO, has issued a Notice of Allowance for key claims covering its proprietary surgical vessel closing pressure...
FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES
Major Carriers Accelerate Route Cuts as Economics Break Down, Creating Multi-Billion-Dollar Opportunity in Regional Air Mobility Flyte Expands Focus on High-Frequency Short-Haul Routes to Capture Surg...
Catheter Precision agreement to acquire Fly Flyte obtains shareholder approval
Catheter Precision (VTAK) announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, executed on March 9. The March 9th transaction establishes Flyte as...
Catheter Precision agreement to acquire Fly Flyte obtains shareholder approval
Catheter Precision (VTAK) announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, executed on March 9. The March 9th transaction establishes Flyte as...
Catheter Precision agreement to acquire Fly Flyte obtains shareholder approval
Catheter Precision (VTAK) announced it received shareholder approval on April 15th of the definitive agreement to acquire Fly Flyte, executed on March 9. The March 9th transaction establishes Flyte as...
New LockeT Data Accepted in Leading Electrophysiology Journal
FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT ...
Catheter Precision engages advisor to sell cardiac electrophysiology business
Catheter Precision (VTAK) announced that it has engaged a strategic advisor to formally market for sale its cardiac electrophysiology business. This strategic initiative is designed to create sharehol...
Catheter Precision Reports 2025 Results and Updates on Strategic Expansion
Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year
Catheter Precision Earnings release: Q4 2025
Catheter Precision released its Q4 2025 earnings on March 31, 2026, summarizing the period's financial results.
Catheter Precision Annual report: Q4 2025
Catheter Precision has published its Q4 2025 annual report on March 31, 2026.
Catheter Precision Proxy statement: Proxy filing
Catheter Precision filed a proxy statement on March 23, 2026, providing details for shareholder voting and corporate governance matters.
Catheter Precision Proxy statement: Proxy filing
Catheter Precision filed a proxy statement on March 23, 2026, providing details for shareholder voting and corporate governance matters.
Catheter Precision announces launch of Flyte Hops Florida
Catheter Precision (VTAK) announced the official launch of Flyte Hops Florida, expanding Flyte’s regional aviation network from its original New York-based service to now providing multiple aircraft a...
Catheter Precision Proxy statement: Proxy Filing
Catheter Precision filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.
Catheter Precision secures up to $88M in institutional financing commitments
Catheter Precision (VTAK) announced balance sheet improvements through new institutional capital commitments supporting the Company’s next phase of growth. Fly Flyte, a newly acquired subsidiary of VT...
Why Is Catheter Precision Stock (VTAK) Up Today?
Catheter Precision stock rallied on Tuesday after the company announced an acquisition deal.
Creatd sells remaining 80% of Fly Flyte to Catheter Precision
Creatd, Inc. (CRTD) has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, to Catheter Precision (VTAK). Under the terms of the completed transaction, Creatd will receive approximately…
Catheter Precision completes acquisition of remaining interest in Fly Flyte
Catheter Precision(VTAK) announced that it has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte from Creatd, Inc. (CRTD), resulting in 100% ownership of the AI-enabled re...
VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.
Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of High-Growth Regional Air Mobility Ahead o...
Catheter Precision’s LockeT suture retention device features at ISLAA 2026
Catheter Precision (VTAK) announced that its LockeT suture retention device will be highlighted during live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference. Th...